Kintara Therapeutics Inc banner

Kintara Therapeutics Inc
F:3DMA

Watchlist Manager
Kintara Therapeutics Inc Logo
Kintara Therapeutics Inc
F:3DMA
Watchlist
Price: 6.951 EUR 1.53% Market Closed
Market Cap: €384.4m

DCF Value

The DCF Value for Kintara Therapeutics Inc (3DMA) under the Base Case is 1.739 EUR. Compared with the current market price of 6.951 EUR, the stock appears Overvalued by 75% .

Key assumptions
3DMA DCF Value
Base Case
1.739
Overvaluation 75%
DCF Value
Price €6.951
Explore More DCF Valuations

Reverse DCF

Single-Assumption Reverse DCF
Stress-test one driver at a time

Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett